Christopher Ohl

6.4k total citations
46 papers, 2.0k citations indexed

About

Christopher Ohl is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Christopher Ohl has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Applied Microbiology and Biotechnology and 12 papers in Epidemiology. Recurrent topics in Christopher Ohl's work include Antibiotic Use and Resistance (13 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Nosocomial Infections in ICU (7 papers). Christopher Ohl is often cited by papers focused on Antibiotic Use and Resistance (13 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Nosocomial Infections in ICU (7 papers). Christopher Ohl collaborates with scholars based in United States and Australia. Christopher Ohl's co-authors include Vera Luther, John Williamson, Christopher D. Paddock, Sherif R. Zaki, Susan McLellan, Jerome Goddard, John W. Sumner, Elizabeth S. Dodds Ashley, James W. Johnson and James Beardsley and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Christopher Ohl

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Ohl United States 21 877 872 504 468 319 46 2.0k
Achilleas Gikas Greece 31 666 0.8× 1.1k 1.2× 428 0.8× 737 1.6× 448 1.4× 112 3.0k
Jan Jelrik Oosterheert Netherlands 29 658 0.8× 845 1.0× 514 1.0× 1.6k 3.5× 206 0.6× 109 2.9k
Hakan Leblebicioğlu Türkiye 32 260 0.3× 1.8k 2.0× 790 1.6× 674 1.4× 335 1.1× 120 3.3k
Farrin A. Manian United States 25 296 0.3× 969 1.1× 196 0.4× 453 1.0× 75 0.2× 84 1.9k
Harold W. Horowitz United States 35 1.2k 1.3× 3.0k 3.5× 552 1.1× 1.5k 3.2× 152 0.5× 93 4.4k
Kurien Thomas India 25 476 0.5× 612 0.7× 600 1.2× 695 1.5× 305 1.0× 71 2.0k
James Meek United States 31 907 1.0× 3.2k 3.7× 624 1.2× 2.4k 5.2× 146 0.5× 87 4.8k
Yiannis Tselentis Greece 27 477 0.5× 519 0.6× 493 1.0× 588 1.3× 52 0.2× 69 1.7k
M Künkel United States 14 368 0.4× 1.1k 1.3× 319 0.6× 563 1.2× 326 1.0× 27 2.0k
Mehmet Doğanay Türkiye 29 186 0.2× 631 0.7× 373 0.7× 1.0k 2.2× 118 0.4× 140 3.1k

Countries citing papers authored by Christopher Ohl

Since Specialization
Citations

This map shows the geographic impact of Christopher Ohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Ohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Ohl more than expected).

Fields of papers citing papers by Christopher Ohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Ohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Ohl. The network helps show where Christopher Ohl may publish in the future.

Co-authorship network of co-authors of Christopher Ohl

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Ohl. A scholar is included among the top collaborators of Christopher Ohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Ohl. Christopher Ohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palavecino, Elizabeth, et al.. (2023). Clinical impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients. SHILAP Revista de lepidopterología. 3(1). e5–e5. 10 indexed citations
2.
Palavecino, Elizabeth, James Beardsley, James W. Johnson, et al.. (2022). A comparison of active versus passive methods of responding to rapid diagnostic blood culture results. SHILAP Revista de lepidopterología. 2(1). e75–e75. 1 indexed citations
3.
Beardsley, James, et al.. (2020). Accuracy of and prescriber perceptions related to documenting antibiotic indications during order entry at an academic medical center. American Journal of Health-System Pharmacy. 77(4). 282–287. 5 indexed citations
4.
Beardsley, James, Elizabeth Palavecino, James W. Johnson, et al.. (2018). 1799. Impact of Real-Time Electronic Notifications to Pharmacists of Rapid Diagnostic Blood Culture Results. Open Forum Infectious Diseases. 5(suppl_1). S510–S510. 3 indexed citations
5.
Wrenn, Rebekah, David B. Cluck, LeAnne Kennedy, Christopher Ohl, & John Williamson. (2017). Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. Journal of Oncology Pharmacy Practice. 24(3). 170–175. 20 indexed citations
6.
7.
Williamson, John, et al.. (2017). Impact of a Stewardship Initiative to Decrease Treatment of Asymptomatic Bacteriuria and Pyuria in the Emergency Department. Open Forum Infectious Diseases. 4(suppl_1). S483–S483. 1 indexed citations
8.
9.
Ohl, Christopher & Vera Luther. (2014). Health Care Provider Education as a Tool to Enhance Antibiotic Stewardship Practices. Infectious Disease Clinics of North America. 28(2). 177–193. 73 indexed citations
10.
Johnson, James W., James Beardsley, David P. Miller, et al.. (2013). Optimizing Empiric Antibiotic Therapy in Patients with Severe β-Lactam Allergy. Antimicrobial Agents and Chemotherapy. 57(12). 5918–5923. 19 indexed citations
11.
Palmer, Hannah R., Elizabeth Palavecino, James W. Johnson, Christopher Ohl, & John Williamson. (2013). Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia. European Journal of Clinical Microbiology & Infectious Diseases. 32(7). 955–959. 34 indexed citations
12.
Ohl, Christopher & Vera Luther. (2011). Antimicrobial stewardship for inpatient facilities. Journal of Hospital Medicine. 6(S1). S4–15. 78 indexed citations
13.
Ohl, Christopher & Elizabeth S. Dodds Ashley. (2011). Antimicrobial Stewardship Programs in Community Hospitals: The Evidence Base and Case Studies. Clinical Infectious Diseases. 53(suppl_1). S23–S28. 98 indexed citations
14.
Luther, Vera, P. Brandon Bookstaver, & Christopher Ohl. (2010). Corticosteroids in the treatment of hepatic tuberculosis: Case report and review of the literature. Scandinavian Journal of Infectious Diseases. 42(4). 315–317. 3 indexed citations
15.
Miller, David P., et al.. (2007). Controlling prescription drug expenditures: a report of success.. PubMed. 13(8). 473–80. 10 indexed citations
16.
Beardsley, James, John Williamson, James W. Johnson, et al.. (2006). Using Local Microbiologic Data To Develop Institution-Specific Guidelines for the Treatment of Hospital-Acquired Pneumonia. CHEST Journal. 130(3). 787–793. 103 indexed citations
17.
Nash, Theodore E., et al.. (2001). Treatment of Patients with Refractory Giardiasis. Clinical Infectious Diseases. 33(1). 22–28. 99 indexed citations
18.
Fowler, Vance G., Carol Hamilton, & Christopher Ohl. (1998). Clostridium septicum myonecrosis presenting as a parapharyngeal abscess in a patient with aplastic Anemia. Infection. 26(5). 309–310. 4 indexed citations
19.
Scoville, Stephanie L., Joe P. Bryan, David R. Tribble, et al.. (1997). Epidemiology, Preventive Services, and Illnesses of International Travelers. Military Medicine. 162(3). 172–178. 20 indexed citations
20.
Pollack, Matthew & Christopher Ohl. (1996). Endotoxin-Based Molecular Strategies for the Prevention and Treatment of Gram-Negative Sepsis and Septic Shock. Current topics in microbiology and immunology. 216. 275–297. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Achilleas Gikas Breakdown of academic impact, for papers by Jan Jelrik Oosterheert Breakdown of academic impact, for papers by Hakan Leblebicioğlu Breakdown of academic impact, for papers by Farrin A. Manian Breakdown of academic impact, for papers by Harold W. Horowitz Breakdown of academic impact, for papers by Kurien Thomas Breakdown of academic impact, for papers by James Meek Breakdown of academic impact, for papers by Yiannis Tselentis Breakdown of academic impact, for papers by M Künkel Breakdown of academic impact, for papers by Mehmet Doğanay
Rankless by CCL
2026